Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for DMSO-Related Nausea and Vomiting in Stem Cell Transplant
NCT00795769Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Aug 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in nausea ((none)), Vomiting, sponsored by Fred Hutchinson Cancer Center. Started Aug 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00795769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795769.